Pharmaceutical Business review

Pfizer, Epocrates Collaborate To Give HCPs Access To Medical Information Group

Pfizer claimed that for the first time, clinicians can make direct contact through the Epocrates drug reference app on their iPhone device to pharmaceutical manufacturers and immediately apply findings to patient care.

Pfizer is enabling easy, direct access to its Medical Information services, via the Epocrates channel, in an effort to enhance the safe and effective use of its medicines, and help improve the quality of patient care.

Pfizer has added that the ‘Contact Pfizer’ is now a feature available in the Epocrates drug profiles of approximately 40 Pfizer products. By providing easy access directly to the manufacturer, this feature provides Epocrates’ users the option for immediate phone access to Pfizer Medical Information specialists to obtain scientific information about the company’s medications and report adverse reactions.

Additionally, healthcare providers are expected to soon have the option to email Pfizer Medical Information for select Pfizer products.

Freda Lewis-Hall, senior vice president and chief medical officer at Pfizer, said: “Healthcare providers have told us they would like direct access to our medical specialists so they can communicate with us in an open, unbiased manner.”

Rose Crane, CEO of Epocrates, said: “Epocrates is committed to providing healthcare providers with the resources they need to make the best clinical decisions for their patients at the point of care.”